D-0338-2018 Class III Terminated

Recalled by Mckesson Packaging Services — Concord, NC

FDA drug recall D-0338-2018 was initiated by Mckesson Packaging Services on Jan 29, 2018 and is designated Class III. Reason for recall: Subpotent Drug: Out of specification for assay (stability testing) The recall status is terminated (terminated Nov 24, 2020). Affected quantity: 24120 cups.

Recall details

Product Type
Drugs
Report Date
Feb 14, 2018
Initiation Date
Jan 29, 2018
Termination Date
Nov 24, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24120 cups

Product description

Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist. By McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51

Reason for recall

Subpotent Drug: Out of specification for assay (stability testing)

Distribution pattern

U.S.A. Nationwide

Code information

Lot #: 0114588, Exp 10/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0338-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0338-2018. Report a data issue: hello@regdatalab.com.